News about 'Video'

This is part two of our interview with Dr. Hesseling. Click here to view part one . Dr. Anneke Hesseling is the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa. She has South African and US training in Medicine and...

Dr. Anneke Hesseling is the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa. She has South African and US training in Medicine and Epidemiology and is the PI and co-PI on several large research projects relates to...

NC001 Today, the TB Alliance announced the first clinical trial to test multiple new TB drugs in combination; the trial is known as New Combination 1 (NC001).The experimental regimen undergoing testing in this trial consists of experimental TB drugs PA-824, Moxifloxacin, and Pyrazinamide, an...

Rebecca, a DOTS Worker with the Global Tuberculosis Institute at UMDNJ, talks about the types of patients she sees and about the possibility of contracting TB herself. Click here to view part one of this interview series.

Rebecca, a DOTS Worker with the Global Tuberculosis Institute at UMDNJ, talks about her experience working with patients at a local shelter.

In June of this year, the WGND interviewed a patient in New Jersey who was being treated by the DOTS program of the Global Tuberculosis Institute at UMDNJ. While his point-of-view is by no means universal, it provides an oft-overlooked window into tuberculosis in the United States. USA TB Patient...

This is part one of our interview, which was recorded on June 9, 2010 at the Global Tuberculosis Institute in Newark, NJ. Dr. Lee Reichman Lee B. Reichman, MD, MPH, is the Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine,...

This story was published on NDTV.com http://origin-netmg.ndtv.com/article/india/the-outcasts-of-tb-tuberculosis-36625 It may be curable but Tuberculosis (TB) remains a stigma in our country especially for women. Over a lakh Indian women are thrown out of their homes each year because they have TB...

Clinical Research Scientist for the TB Alliance This video was recorded on November 13, 2009 at Johns Hopkins University. Dr. Martino Laurenzi Dr. Laurenzi, an expert in clinical development and community health, is a Clinical Research Scientist at the TB Alliance, where his responsibilities...

Professor of Medicine, University of Colorado School of Medicine, Denver, Colorado This video was recorded on November 13, 2009 at Johns Hopkins University. Michael D. Iseman Dr. Michael D. Iseman is a Professor of Medicine in the Divisions of Pulmonary Medicine and Infectious Diseases at the...

Professor of Microbiology and Immunology and of Molecular Genetics, Albert Einstein College of Medicine. This video was recorded on November 13, 2009 at Johns Hopkins University. Dr. Bill Jacobs Jacobs moved to Albert Einstein College of Medicine in 1985 to become a postdoc with Barry Bloom, who...

Dr. Gyanu Lamichhane is Assistant Professor, Division of Infectious Diseases at the Johns Hopkins University Center for Tuberculosis Research Labs. This interview was conducted at JHU on November 13, 2009. The following bio is excerpted from this bio sketch (.pdf – 80kb) , which includes a list of...

Dr. Joel S. Freundlich Dr. Joel S. Freundlich attended Cornell University as a McMullen scholar and an Exxon scholar, attaining his B.S. degree with Distinction in Chemical Engineering in 1991 and his M. Eng. degree in Chemical Engineering in 1992. He received his Ph.D. degree in 1996 in Organic...

FT.com For World TB Day, the Financial Times’ Andrew Jack interviewed various members of the TB community to get their take on a range of topics: Paul Stoffels, head of R&D at Johnson & Johnson , explains why drugs to cope with tuberculosis have been slow to emerge from the pipelines of the...

Dr. Barbara Laughon Dr. Barbara Laughon works in the Office of the Director, Division of Microbiology and Infectious Diseases at the National Institute of Allergy & Infectious Diseases (NIH/NIAID) . She is also a Core Group member of the Working Group on New TB Drugs and is the Candidates...